Meningococcal Vaccines Market, By Vaccine Type (Polysaccharide, Conjugate, Combination), By Distribution Channel (Government, Private), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Op

Meningococcal Vaccines Market, By Vaccine Type (Polysaccharide, Conjugate, Combination), By Distribution Channel (Government, Private), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Meningitis is an inflammation in the inner lining of the brain and spinal cord that results from infectious (viral, bacterial, and rarely fungal) or non-infectious (drugs, sarcoidosis etc.) factors. The swelling associated with meninges triggers symptoms such as painful headaches, fever, loss of appetite, and stiffness of the neck. Meningitis is a fatal disease and has a rapid onset of action. Meningitis can cause severe damage to the brain in almost half of the total infected population, if untreated. It can also lead to serious ailments such as mental retardation, epilepsy, and deafness. According to Meningitis Research Foundation, as of 2017, around 80% - 90% of meningitis cases are estimated to be caused by enteroviruses and the remaining 10% is estimated to be caused by herpes virus, mumps, measles, and human immune deficiency virus.
Restraints of the Global Meningococcal Vaccines Market
High cost of meningococcal vaccination and low coverage of the same are expected to hinder growth of the global meningococcal vaccines market.
Key features of the study:
This report provides in-depth analysis of the global meningococcal vaccines market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global meningococcal vaccines market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Baxter International, Inc., Biomed Pvt. Ltd., GlaxoSmithKline plc, JN-International Medical Corporation, Novartis International AG., Pfizer, Inc., Sanofi SA, and Serum Institute of India Ltd.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global meningococcal vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Meningococcal Vaccines Market, By Vaccine Type:
Polysaccharide
Conjugate
Combination
Global Meningococcal Vaccines Market, By Distribution Channel:
Government
Private
Global Meningococcal Vaccines Market, By Geography:
North America
By Vaccine Type
Polysaccharide
Conjugate
Combination
By Distribution Channel
Government
Private
By Country:
U.S.
Canada
Europe
By Vaccine Type
Polysaccharide
Conjugate
Combination
By Distribution Channel
Government
Private
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Vaccine Type
Polysaccharide
Conjugate
Combination
By Distribution Channel
Government
Private
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Vaccine Type
Polysaccharide
Conjugate
Combination
By Distribution Channel
Government
Private
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Vaccine Type
Polysaccharide
Conjugate
Combination
By Distribution Channel
Government
Private
By Country:
GCC
Israel
Rest of Middle East
Africa
By Vaccine Type
Polysaccharide
Conjugate
Combination
By Distribution Channel
Government
Private
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Baxter International, Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Biomed Pvt. Ltd.
GlaxoSmithKline plc
JN-International Medical Corporation
Novartis International AG
Pfizer, Inc.
Sanofi SA
Serum Institute of India Ltd.
“*” marked represents similar segmentation in other categories in the respective section.